Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate as a Metabolic Intervention for COVID-19 (FERMIN trial)
2021-000843-33Phase 2Completed
- Sponsor
- Hellenic Institute for the Study of Sepsis
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of fenofibrate in coronavirus disease 2019 (COVID-19) and coronavirus pneumonia (2 arms), sponsored by Hellenic Institute for the Study of Sepsis. Primary endpoint: Global rank score for patient outcomes. Started Mar 2021; status: completed.
02
Drugs
fenofibrate
03
Conditions
coronavirus disease 2019 (COVID-19)coronavirus pneumonia
Beyond the preview
Go deeper on 2021-000843-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000843-33.